Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent and morbid disease
marked by irreversible structural changes in the lungs. Bronchoscopic therapies have …

Bronchoscopic lung volume reduction (BLVR) procedure has expanded the treatment
spectrum of patients with end-stage emphysema. These treatments include valve, coil …

Several bronchoscopic lung volume reduction (BLVR) treatments have been developed to
reduce hyperinflation in emphysema patients. Lung bio-adhesives are among the most …

Emphysema is an incurable and underdiagnosed disease with obstructive ventilatory
impairment of lung function. Despite decades of research, medical treatments available so …

Background The new endobronchial therapy called biological lung volume reduction
(BioLVR) involves using a rapid polymerizing sealant to block off the most emphysematous …

Chronic obstructive pulmonary disease is a prevalent and progressive disease. The recently
developed bronchoscopic lung volume reduction (BLVR) techniques offer personalized …

Background: Bronchoscopic therapies are less invasive alternatives of surgical lung volume
reduction for severe emphysema. Bending of lung tissue by implanting metallic coils into …

Although there are multiple pharmacologic and nonpharmacological options to alleviate
symptoms of emphysema, none of these treatment modalities halts disease progression …

Biological lung volume reduction (BioLVR) is a novel and low-cost endobronchial treatment
method aimed at reducing the volume of the target lung lobe using biological agents …

Bronchoscopic interventions are valuable adjuncts to the pharmacologic therapy for chronic
obstructive pulmonary disease (COPD). But different phenotypes of COPD patients showed …